The dietary supplement industry, a vital component of the wellness economy supporting millions of consumers and thousands of businesses, is facing a critical juncture. Over the past decade, a growing wave of state-level legislative proposals aims to restrict access to a wide array of dietary supplements, including popular products like creatine, amino acids, and other nutritional compounds. These proposals, while varying in specifics, generally advocate for moving such products behind the counter, necessitating identification for purchase, effectively equating them with age-restricted items like alcohol and tobacco. This shift in regulatory approach presents a significant challenge to an industry that views its products as integral to promoting daily health and well-being.
This evolving regulatory environment underscores the urgent need for robust engagement from all stakeholders within the dietary supplement supply chain in the policymaking process. Recognizing this imperative, the Natural Products Association (NPA) is set to host its annual Fly-In Day in Washington, D.C., on May 12, 2026. This event serves as a crucial platform for industry leaders to directly communicate with lawmakers and their staff, advocating for policies that support innovation, consumer access, and regulatory clarity.
The genesis of these legislative efforts can be traced to a broader societal conversation about consumer safety and product oversight. However, the NPA argues that classifying health-promoting supplements alongside controlled substances is an "irrational framework" that fails to acknowledge the distinct nature and benefits of these products. As Kyle Turk, Director of Government Affairs for the NPA, notes, "Policymakers are increasingly discussing regulations that would treat certain supplements more like alcohol or tobacco than the wellness products millions of Americans rely on every day to promote their health." This perspective highlights the core tension: a perceived need for increased oversight versus the industry’s stance that current regulations, when properly understood and applied, are sufficient.
A Decade of Shifting Policy: A Chronology of Legislative Trends
The past ten years have witnessed a consistent uptick in legislative activity targeting dietary supplements at the state level. While no single event triggered this trend, it has been influenced by a confluence of factors, including heightened public awareness of health and wellness products, a desire to address potential misuse or adverse events, and the increasing sophistication of legislative advocacy from various interest groups.
- Early 2010s: Initial legislative proposals at the state level were often narrowly focused, addressing specific ingredients or product categories perceived to be at higher risk. These early efforts laid the groundwork for more comprehensive regulatory discussions.
- Mid-2010s: The scope of proposed legislation broadened, with some states exploring measures to restrict sales to minors or implement stricter labeling requirements. Discussions around requiring identification for certain supplements began to emerge in earnest.
- Late 2010s: The concept of placing supplements behind the counter, similar to over-the-counter medications requiring pharmacist consultation, gained traction in several states. This period also saw increased attention from federal agencies on the regulatory framework for supplements.
- Early 2020s: The COVID-19 pandemic, with its surge in interest in immune-boosting supplements, inadvertently amplified both consumer demand and regulatory scrutiny. Debates intensified regarding the efficacy and safety of various products, leading to further legislative proposals aimed at controlling access.
- Present Day (leading up to May 2026): The trend continues, with dozens of states considering legislation that could significantly alter how consumers purchase and access dietary supplements. The NPA’s Fly-In Day is a direct response to this ongoing legislative push.
The Power of Direct Engagement: Understanding the Legislative Process
From his vantage point as a former state legislative staffer, Kyle Turk emphasizes the critical role of direct engagement in shaping policy. "Lawmakers are often working with extremely limited policy resources," Turk explains. "In many state legislatures, there may be one or two staff members responsible for policy across a wide range of issues, from health care to transportation and higher education." This limited capacity means that legislative staff members, including those on Capitol Hill, rely heavily on outside experts for information and analysis when complex topics like dietary supplement regulation arise.
The absence of industry voices in these crucial conversations can lead to decisions based on incomplete information, flawed assumptions, or the biased perspectives of groups that may not fully grasp the intricacies of the supplement marketplace. The NPA’s annual Fly-In Day is designed to fill this informational void. By bringing together representatives from across the dietary supplement supply chain – from ingredient suppliers to manufacturers and retailers – the event facilitates direct dialogue with members of Congress and their staff.
"These meetings provide lawmakers with something they rarely receive during policy debates: practical insights from the people who develop, manufacture, and sell these products," Turk states. This direct testimony offers policymakers a tangible understanding of the research, development, and compliance efforts that underpin the industry, humanizing the policy debates and highlighting the real-world implications of regulatory decisions.
Key Policy Arenas: HSA/FSA Access and Drug Preclusion
The discussions held during NPA’s Fly-In Day and throughout the year often center on issues with direct and significant implications for the industry’s future. Two prominent areas of focus are the expansion of Health Savings Account (HSA) and Flexible Spending Account (FSA) eligibility for dietary supplements and the resolution of the drug preclusion clause within the Dietary Supplement Health and Education Act of 1994 (DSHEA).
HSA/FSA Supplement Allowance Movement
A significant legislative push involves expanding consumers’ ability to utilize HSAs and FSAs for the purchase of dietary supplements. The NPA has been actively working with a bipartisan group of lawmakers to advocate for allowing supplements to be purchased through these accounts without the requirement of a prescription. This policy change is framed as a logical step towards encouraging preventive health measures, particularly at a time when millions of Americans are increasing their investment in proactive wellness strategies.
The economic and public health rationale for this policy shift is compelling. By enabling individuals to use pre-tax dollars for supplements, the proposal aims to make health-promoting products more accessible and affordable, thereby fostering greater consumer investment in their well-being. The fact that this proposal is gaining traction across government indicates a growing recognition of the potential benefits. Industry leaders’ direct engagement in these conversations is seen as instrumental in advancing this initiative, providing policymakers with the data and perspectives needed to understand its far-reaching positive impact.
Drug Preclusion Resolution Needed
Another critical issue shaping policy discussions on Capitol Hill is the ambiguity surrounding the drug preclusion clause within DSHEA. This clause has created significant uncertainty for suppliers of innovative ingredients, including N-acetyl-L-cysteine (NAC) and (β)-Nicotinamide Mononucleotide (NMN), among other emerging compounds. Companies that are investing heavily in the research and development of the next generation of dietary supplements require regulatory clarity to continue their work without the fear of their products being reclassified.
The current interpretation of the drug preclusion clause has led to situations where novel ingredients, developed for the supplement market, face potential classification as unapproved drugs, thereby creating a barrier to market entry and stifling innovation. Both regulators and lawmakers are increasingly acknowledging this challenge. Conversations are underway regarding how Congress can provide legislative clarification to Section 201(ff) of the Federal Food, Drug & Cosmetic Act, which DSHEA amended over three decades ago.
This regulatory uncertainty has tangible consequences. It impacts investment decisions, job creation within the industry, and ultimately, consumer access to potentially beneficial new products. The NPA’s Fly-In Day provides a platform for companies to articulate the significant research and development investments behind these novel ingredients and to underscore the necessity of regulatory certainty for sustained innovation. When policymakers hear directly from the companies involved about the scientific rigor and compliance efforts behind new products, it reframes the drug preclusion debate from an abstract regulatory discussion to one with concrete economic and consumer welfare implications.
The Broader Impact: Consumer Access and Industry Viability
The ramifications of these legislative and regulatory trends extend far beyond the industry itself. For consumers, a significant restriction on access to dietary supplements could mean a reduction in their ability to manage their health proactively. Millions of individuals rely on these products to supplement their diets, support specific health goals, and enhance their overall well-being. Any policy that creates barriers to access could disproportionately affect vulnerable populations or those who have found specific supplements beneficial for their health regimens.
From an economic perspective, the dietary supplement industry represents a substantial segment of the U.S. economy. It supports thousands of small and medium-sized businesses, creates numerous jobs, and contributes to innovation in the health and wellness sector. Unfavorable regulatory changes could lead to reduced investment, job losses, and a decline in the industry’s capacity to innovate and serve consumer needs.
The ongoing debate also highlights a critical aspect of democratic governance: the importance of an informed and engaged citizenry. In an era where legislative decisions are increasingly influenced by data and expert testimony, the active participation of industry stakeholders in the policymaking process is not merely beneficial but essential. The NPA’s Fly-In Day embodies this principle, empowering companies to share their stories, present their data, and advocate for policies that reflect the realities of their operations and the needs of their customers.
Looking Ahead: A Call for Continued Engagement
As the dietary supplement industry navigates this complex regulatory landscape, the message from organizations like the NPA remains clear: proactive and consistent engagement is paramount. Fly-In Day is more than just a single event; it is a symbol of an ongoing commitment to building relationships with policymakers, educating decision-makers about the industry’s contributions, and ensuring that the voices of responsible companies are heard.
The current environment, characterized by a surge of proposals to restrict access to dietary supplements, demands a unified and persistent effort. The industry’s narrative—one of supporting millions of consumers, fostering thousands of businesses, and contributing to a growing focus on preventive health—must be effectively communicated to those who craft the laws and regulations that govern it. The continued participation of companies across the natural products sector in initiatives like NPA’s Fly-In Day is a testament to their understanding of this fundamental truth. By showing up, sharing their experiences, and advocating for sensible policies, these companies are actively working to shape a future where consumer access to health-promoting products is preserved and innovation is fostered.